ABSTRACT. Calcium antagonist therapy has been reported to reduce neuronal death after hypoxia-ischemia; however, its potential use in prenatal hypoxic-ischemic events has received little attention. We examined the effect of pretreatment with flunarizine in chronically instrumented late gestation fetal sheep subjected to 30 min of cerebral ischemia. Eight fetuses were given 0.1 1 mmol(45 mg) of flunarizine over 2 h preischemia (high dose), 10 were given 0.07 mmol (30 mg) over 3 h preischemia (low dose), 17 were given nothing (ischemia controls), and 5 received neither the ischemic insult nor any treatment (sham controls). The fetal electrocorticogram was monitored for 3 d postinsult. Histologic outcome was quantified after 72 h. Low-dose, but not high-dose, flunarizine therapy was associated with an overall reduction in cerebral damage (p < 0.01), a greater final electrocorticogram intensity, and a reduction in the incidence of seizures ( p < 0.02) compared with ischemia controls. High-dose, but not lowdose, flunarizine was associated with a significant acute mortality and a decrease in fetal blood pressure ( p < 0.05) at the time of occlusion, although there was no effect on the initial hypertensive response to occlusion. These observations suggest that flunarizine is partially neuroprotective when given before severe global ischemia in utero, but that its hypotensive effects make it unsuitable for prophylactic administration in utero. (Pediatr Res 35: 657663, 1994) 
at the time of occlusion, although there was no effect on the initial hypertensive response to occlusion. These observations suggest that flunarizine is partially neuroprotective when given before severe global ischemia in utero, but that its hypotensive effects make it unsuitable for prophylactic administration in utero. (Pediatr Res 35: 657663, 1994) damage from such insults in adult (2, 3) and immature (2, (4) (5) (6) animals.
Perinatal hypoxic-ischemic encephalopathy affects approximately six of 1000 term infants (7) and occurs primarily prepartum or intrapartum (8) . Although the safety of anteparturn treatment of compromised fetuses is unresolved (9) , prophylactic use of neuroprotective agents may be possible in at-risk infants (6) . Flunarizine is a lipid-soluble calcium channel antagonist known to pass the blood-brain and placental bamers and to inhibit depolarization-induced uptake of calcium (2) . We have previously shown flunarizine to be dramatically protective in infant rats when given before 2 h of hypoxia-ischemia (5). We have recently described an experimental approach to global cerebral ischemia in utero that produces severe delayed postischemic epileptiform activity with parasagittal cortical infarction (10, 1 1). This pattern is similar to that seen in some asphyxiated term infants, supporting the hypothesis that parasagittal hypoxicischemic encephalopathy is of ischemic origin, resulting from a period of impaired cerebral perfusion (8, 12) . This preparation, which allows a reproducible insult to be delivered to a stable animal, without systemic compromise, is very suitable for testing possible therapeutic interventions in hypoxic-ischemic encephalopathy. Ultimately of course, promising interventions also need to be tested using a more pathophysiologic, and more variable, asphyxia1 approach (13) . In this study, we tested the effect of flunarizine when given immediately before 30 min of cerebral ischemia in the fetal sheep.
Abbreviations MATERIALS AND METHODS

BP, arterial blood pressure
Forty eight Romney/Suffolk fetal sheep from 116 to 126 d of CBF, cerebral blood flow gestation were instrumented under halothane anesthesia (2%) as ECoG, electrocorticogram previously described ( 10) . The electrophysiologic and histologic FHR, fetal heart rate outcome in 14 of the fetuses (nine ischemia controls and five NGF, nerve growth factor sham controls) have previously been reported ( 10, 1 1 ). Briefly, MANCOVA, multivariate analysis of covariance catheters were inserted into the brachial arteries and vein and amniotic cavity. Two pairs of shielded stainless steel electrodes were placed over the parietal dura, at 10 mm lateral to the bregma, and 5 mm and 15 mm anterior to the bregma. The vertebral-occipital anastomoses between the carotid arteries and Calcium entry secondary to ischemic depolarization and ex-vertebral arteries were ligated bilaterally to eliminate vertebral citatory neurotransmitter release is one mechanism leading to blood supply to the brain. Inflatable occluder cuffs were placed neuronal death after a hypoxic-ischemic insult ( I ) . There is around both carotid arteries. The fetus was then returned to the increasing experimental evidence that prophylactic treatment uterus, the leads and catheters externalized to the maternal flank, with calcium channel blockers can reduce the degree of cerebral and the uterine and sutured As part of a pilot study, four of the fetuses were instrumented as above, but
GUNN ET AL.
Antibiotics (penicillin, 1 g; gentamicin, 80 mg) were administered daily for 4 d starting at surgery. All experiments were started 72 to 96 h after surgery. Recordings. The fetal parietal ECoG from 1 to 30 Hz was recorded and its intensity (power) spectrum analyzed in real time as previously reported (10, 14) for 4 h before any intervention and for 72 h postinsult; the ECoG was also recorded on an analog chart running at 5 mm/min. Fetal BP, corrected for amniotic fluid pressure, was recorded using the Real-Time Data Acquisition System [developed by P.S. Dale (IS)] and averaged at I-min intervals for 2 h before any intervention and for 1 h after the occlusion. Before experimentation, arterial blood samples were analyzed for blood gases, pH, oxygen saturation, Hb, and lactate, and only fetuses with normal arterial blood gases for our laboratory (pH > 7.3 and arterial oxygen tension > 2.27 kPa) were used.
Experimental procedures. Flunarizine (Janssen Pharmaceutica, Beerse, Belgium) was dissolved in 1 mL of Tween 80 (polysorbate 80) per 150 mg of flunarizine, and then made up to 10 mL with saline. It was administered systemically as a slow infusion through the brachial vein. As part of a pilot study, four fetuses received infusions of 0.22 mmol (90 mg) of flunarizine over 1 h (approximately 10 mg/kg of fetal weight). This was associated with a significant decrease in BP of 15.6 + 7% at the end of the infusion but not at the time that half the infusion had been given (-2 i 4%). A similar infusion of the diluent only, 2 d later, had no effect on fetal BP (-0.5 * 2%). We therefore chose to begin our study with a dose of 0.11 mmol (45 mg) of flunarizine over 2 h. Because of a number of complications, including hypotension and unexplained death, described in the results, the dose and infusion rate were subsequently reduced to 0.07 mmol (30 mg) over 3 h. These two dose groups were considered separately.
Cerebral ischemia was induced by inflating the carotid cuffs with saline for 30 min, and successful occlusion was confirmed by the rapid (<30 s) suppression of the ECoG to isoelectricity. Because we have found that a number of cuffs burst immediately after inflation, we prospectively chose to use animals in whom this occurred as sham controls for changes in ECoG intensity over the subsequent 3 d and for histologic outcome (10) .
The experimental fetuses were 125 k 3 d old (1 19-13 1 d) at the time of the insult, and their postmortem weights (3.2 + 0.5 kg) were normal by the standards of our laboratory; these parameters were not significantly different between the treatment groups. On the day of experimentation, animals were assigned to either control or flunarizine-treatment groups, as shown in Table 1 . Eight fetuses were given 0.1 1 mmol (45 mg) of flunarizine over 2 h, starting 1.5 h preischemia (high-dose group); 10 fetuses were given 0.07 mmol (30 mg) over 3 h, starting 2.5 h preischemia (low-dose group); and 17 were ischemia controls. The infusion was timed to finish at the end of carotid occlusion. In addition, there were five sham controls (no treatment), and four flunarizine-treated fetuses whose cuffs failed ( overdose of pentobarbital, and histologic sections of the brains were obtained as previously described ( 10) ; no histology was performed on fetuses that died during or shortly after the insult. Briefly, the brain was perfused through the common carotid arteries with saline followed by 10% formalin, embedded in paraffin, coronally subserially sectioned to 8 p M , and then stained with thionine-acid fuchsin (16) . Each section was examined with light microscopy by two assessors, one of whom was blind to the study. Each region was scored in a number of preassigned areas for the proportion of neurons with ischemic cell change, with acidophilic (red) cytoplasm and contracted nuclei, or with just a thin rim of red cytoplasm with pyknotic nuclei. Such cells were assessed as dead and all others were considered viable. The damage scores were as follows: 0 = no dead neurons, 5 = >0-lo%, 30 = >lo-50%, 70 = >50-90%, 95 = 90-<loo%, and 100 = 100% dead neurons (10, 1 1). Each score corresponds with the midpoint of its range. The score for each region consisted of the average of the scores for all spots assessed within that region. The proportion of areas within the parasagittal cortex showing infarction, with evidence of death of glia as well as neurons ( I 6), was also recorded.
Analysis. ECoG intensity (power) was log transformed
[dB, 10 . log(intensity)], because this transformation gives a better approximation of the normal distribution (1 7). The intensity was then normalized with respect to the 4-h control period; thus, all measurements are expressed as a ratio of the baseline period. Time-series analysis of the ECoG data was based on data smoothed with a digital Blackman low-pass filter to minimize short-term (<lo-min) fluctuations. The final ECoG intensity was calculated on the final 4-h period, from 68 to 72 h; the preseizure intensity was based on a I-h period immediately before the start of seizures, as determined from the analog trace. The suppression time of the ECoG was defined as the time postinsult that the ECoG was more than 5 dB below the baseline intensity, whereas the start of postinsult seizure activity was defined as the 10% point of increase to the peak. We have previously shown that this abrupt increase in intensity, with a marked decrease in median frequency, corresponds with tonic-clonic activity recorded by diaphragmatic electromyogram (10) . The median frequency of the ECoG was calculated from saved spectra at four periods: the 4-h control, during the infusion, from 5 to 30 h, and from 68 to 72 h. Because of technical failure of the ECoG recording, two ischemia controls and one low-dose animal were rejected from the analysis of the postinsult ECoG results. For technical reasons, cardiovascular recordings were not available for seven ischemia controls and three low-dose fetuses.
Comparisons of histology, ECoG, biochemical, and cardiovascular parameters were made by multivariate analysis of variance. Cerebral region and time were treated as repeated measures, to allow for repeated sampling. For comparisons over time, baseline levels were used as a covariate (MANCOVA). Where significant differences were found, post hoc comparisons of the means were made using the Neuman-Keuls test and adjusted using the baseline levels as the covariate, whereas changes relative to baseline were tested with the Wilcoxon paired comparisons test. Fisher's Exact test was used to test proportions.
RESULTS
Ischemia controls.
After 30 min of bilateral carotid occlusion, with complete suppression of the ECoG during ischemia, the ECoG remained suppressed to less than 5 dB for 6.9 k 2.6 h (Fig. 1) . Continuous, intense, low-frequency epileptiform activity appeared after 7.6 * 3.2 h and peaked after 10.0 & 5.3 h; the ECoG intensity for the I-h period immediately preceding the onset of seizures was very suppressed ( Table 2 ). The epileptiform activity progressively resolved over the following 48 h, and by 72 h postinsult the ECoG intensity was dramatically reduced compared with baseline intensity ( (n = 2, before ischemia) or shortly after the end of flunarizine infusion (n = 1, during ischemia). In surviving animals (n = 5),
there was a similar overall pattern of changes in ECoG activity in the ischemia controls (Table 2) . Although the ECoG suppression time was shorter (4.2 + 2.2 h, p < 0.05), the peak intensity occurred at a similar time (10.5 + 6.9 h) and was of similar magnitude. The preseizure and final ECoG intensities were not significantly different from those of ischemia controls (Table 2) . During the last 30 min of flunarizine infusion before occlusion, there was a slight shift to lower frequencies (Table 3) parasagittal areas showed infarction ( p < 0.02 versus controls). Table 2 ), although they were still significantly lower than end of the insult. The ischemia control fetus showed marked suppression in sham controls. Although five fetuses developed delayed conof the ECoG for about 9 h after the insult, then developed continuous tinuous seizure activity as seen in the ischemia controls, the intense low-frequency epileptiform activity. In the flunarizine-treated remaining five showed a modified pattern (Fig. 1 ) of greater animal (bollom), the recovery in ECoG intensity was greater and more preseizure recovery of the ECoG, followed by a small number of rapid before the onset of isolated episodes of intense epileptiform activity. discrete episodes of intense epileptifom activity ( p < 0.02,
Fisher's Exact test). of the ECoG decreased postinsult and remained low at 72 h
The median frequency of the ECoG showed a significantly (Table 3) .
better recovery compared with that of ischemia controls ( p < A mild metabolic acidosis developed during carotid artery 0.05, Table 3 , MANCOVA), with a higher median frequency by occlusion ( p < 0.05, Table 4 ), accompanied by a trivial increase 72 h. There was a small shift to lower frequencies during flunarin oxygen content that was not different between the treatment kine infusion compared with baseline (P < 0.05).
groups. The arterial carbon dioxide tension showed no significant Significant hypotension did not occur during infusion ( p = changes in any group (6.88 + 0.56 kPa). Changes in fetal cardi-0.3), but the pattern of changes in BP was significantly changed ovascular parameters are shown in Table 5 . Carotid artery occlu-( p < 0.01), with a blunted increase during and immediately after sion caused a dramatic increase in fetal Bp ( p < 0.01) that occlusion ( Table 5 ). The pattern of changes in fetal heart rate peaked at 6.2 + 2.0 min and resolved rapidly after release. A and the metabolic factors was not significantly altered compared progressive tachycardia during occlusion also was seen. with that in ischemia controls (Tables 4 and 5 ). Histologic analysis of these 17 ischemia control fetuses (Fig. Neuronal loss was reduced in treated animals ( p < 0.001, 2) showed that there was severe neuronal loss in a watershed multivariate analysis of variance). The improvement was most pattern, with predominant damage in the parasagittal cortex, dramatic in the cortex and striatum ( p < 0.001), with a lesser with laminar necrosis, and in the hippocampus. In 72 + 16% of degree of protection in the hippocampus ( p < 0.05) and no parasagittal areas there was evidence of infarction.
significant difference in the CA3 subfield (Fig. 2) . Parasagittal
High dose. Three high-dose but no control (sham or ischemia) infarction was correspondingly reduced to 20 + 20% of the areas or low-dose animals developed an abmpt, severe bradycardia assessed ( p < 0.001). and hypotension and died ( p < 0.02, Fisher Exact test) during
Stepwise multiple linear regression analysis of ECoG changes ECoG intensity is expressed in db (mean + SD) relative to the baseline In contrast, rescue therapy, although a more clinically viable period. Compared with baseline and with the sham controls, all three Strategy, seems to be much less effective. Clinical studies of experimental groups showed a marked decrease in median frequency treatrl'lent with calcium antagonists after cardiac aITeSt (19) Or between 5 and 30 h postinsult, corresponding with low-frequency spike pennatal asphyxia (20) have found no clear benefit. Indeed, wave activity at that time. In both the ischemia controls and the high-LC!vene et (20) reported that an hcremental infusion of dose group, the median frequency remained low even after resolution of nicardipine, starting within 12 h of severe asphyxia, was associthis phase, at 72 h, but the low-dose group showed significant improve-ated with severe hypotension in two of four cases. ment ( p c 0.05, MANCOVA).
These data are consistent with the experimental evidence. t p c 0.05 compared with the baseline period.
Although Thiringer el al. (21) reported enhanced recovery of S p < 0.05 vs sham controls.
somatosensory evoked potentials after treatment with 3 mg of $ p c 0.05 vs ischemia controls.
lidoflazine 2 h after 10-1 5 min of cardiac arrest in newborn sheep, the cocktail of compounds given and the excessively short in experimental fetuses against damage in the underlying para-follow-up limit interpretation. Nimodipine did not improve CBF sagittal cortex suggested that both the duration of suppression or ECoG recovery after 5 min of total asphyxia in the beagle PUP postinsult ( r = 0.45) and the final ECoG intensity (22) , and flunarizine did not reduce cerebral damage in the infant (r = -0.74, Fig. 3 ) were correlated with damage in the underlying rat after severe hypoxia-ischemia (23) . In adult species, although cortex (? = 0.9, p c 0.001). Although the peak (seizure) intensity an early study reported global protection with flunarizine treatwas not significantly associated with neuronal loss ( r = -0.17), ment (241, subsequent studies have found either no improvement the difference between peak intensity and ECoG intensity before (3) or reduced damage only in the hippocampus (1, 3, 25, 26 ), the onset of seizures did show a weak correlation ( r = 0.46, p < which is the region where delayed, excessive calcium entry has 0.05). The fetuses with intermittent rather than continuous been most clearly documented ( 1, 27). postinsult seizure activity also showed a markedly lower proporIn this study, we found greatest improvement in the cortex, tion of the parasagittal cortex with infarction (6.7 9.7 versus with the least protection from damage in the hippocampus. This 66.7 & 21.3%, p < 0.001). The final ECoG intensity and the difference compared with the preferential improvement in the preseizure intensity were closely intercorrelated ( r = 0.82, p c hippocampus found in many adult studies (3) might be related 0.001).
to a number of factors, including the immaturity of the fetal brain, the stable thermal environment in utero, and the prophy-DISCUSSION lactic approach used. In addition, rats developing overt seizures are usually excluded from adult studies of ischemia (28), which This is the first large-animal study confirming that an appro-may well alter the pathogenesis of damage (29) . priate dose of a calcium antagonist can protect the fetal brain
The slight increase in arterial lactate levels during and immefrom ischemic injury. Fetuses treated with a low dose showed a diately after ischemia is almost certainly caused by cerebral more rapid and complete recovery of ECoG activity after ische-anaerobic metabolism during ischemia, which may only have mia. These electrophysiologic improvements were associated partially resolved by 30 rnin postischemia (30) . Because uterowith a dramatic reduction in damage in the underlying cortex. placental lactate transport has a limited rate, the extra lactate High-dose therapy, which was associated with a consistent mild produced would not be expected to be fully cleared by that time hypotension and significant mortality, did not significantly amel-(3 1). iorate neuronal loss, although the extent of infarction was re-
The primary mechanism of any neuroprotective effect has not duced.
been established. Flunarizine is a lipophilic calcium channel One ofthe few clinical situations in which prophylactic therapy antagonist binding to the dihydropyridine binding site (2). Its Lactate levels were not measured at the time of death. t p < 0.05 compared with preocclusion values. There was no significant difference between flunarizine-treated and ischemia control animals for any metabolic parameter. * Baseline = 2-h period before any intervention; Infusion = final 30 min before occlusion; Peak = peak BP or fetal heart rate during occlusion; Occlusion = mean level during occlusion; and Recovery = mean BP for 60 min after occlusion. Values are mean + SD. The highdose group (n = 5) showed a significant overall reduction in BP compared with the ischemia controls (n = 10) ( p = 0.02, MANCOVA). The lowdose group ( n = 7) did not show a significant overall reduction but showed a significant alteration in the pattern of BP changes ( p < 0.01) with a blunted response to carotid occlusion. An increase in heart rate developed during occlusion that was not significantly different between the groups (MANCOVA). that has been reported to increase levels of the inhibitory purine adenosine by affecting reuptake and to alter neurotransmitter and in the fetal sheep are associated with a secondary increase in intracellular edema, suggesting that this period is associated with delayed neuronal death (29). Although we found in this study that fewer treated fetuses showed continuous high-intensity seizure activity and that this reduction in seizure activity was associated with a very large reduction in the amount of cortical infarction, the significantly earlier and better recovery of ECoG activity before the onset of seizures suggests that neuronal protection during the insult and possibly immediately afterward was more important than reduced secondary damage.
The other major possible mechanism of action is improved CBF due to selective cerebral vasodilation (2) during or after the insult. Althoueh flunarizine has been re~orted to i m~r o v e CBF during or afte;hypoxia-ischemia (2), alte'rations in CBF induced by the calcium channel antagonists have not been consistently related to improvement in neurologic damage (3). Both no improvement in outcome despite increased CBF (3) and reduced damage despite no alteration in CBF during global ischemia (38) have been reported. Because it has been suggested that loss of autoregulation means CBF is essentially pressure passive during and immediately after hypoxia-ischemia in the newborn (39) , the hypotension that occurred in the high-dose group in this study may have compromised recirculation after release of the carotid cuffs and thus may explain the reduction in protective effect seen at this dose. Nevertheless, the low-dose group showed dramatic protection despite an impaired BP response to carotid occlusion.
Other interactions might also influence the differing effects at different doses. Flunarizine is reported to prevent the secondary degeneration of NGF-dependent cholinergic basal forebrain neurons seen after axonal transection (40) . The mechanism is unclear, but may again be related to effects on calcium entry. In peripheral sensory neurons studied in vitro, NGF acts reciprocally with neuronal activity to improve survival by stabilizing calcium homeostasis (41) . In hippocampal pyramidal cells in vitro, IGF-I and IGF-11, fibroblast growth factor, and NGF are associated with a dose-related reduction in calcium entry and improvement in survival during hypoglycemia or exposure to excess dutamate 142.43). NGF release is affected bv interactions with ;her gowt'h factors such as the cytokine transforming growth factor-@ (44). Transforming growth factor-p has recently been reported to dramatically reduce damage after severe hypoxia-ischemia in the rat at intermediate doses but not at either high or low doses (45) . These data suggest that complex interactions between endogenous (or exogenous) neurotrophic factors, voltage-dependent calcium channels, and neurotransmitters are likely to be involved in determining neuronal survival in hypoxicischemic encephalopathy.
Calcium antagonists have been used to reduce uterine activity but have been suggested to compromise fetal circulation (9). Jensen and Klossek (46) report that an i.v. bolus of 1 mg of flunarizine per kg 60 min before 2 min of total fetal asphyxia in the fetal sheep caused only a transient period of hypotension, which is consistent with our data. Although there was an increase in CBF to some parts of the brain, there was a trend toward reduced placental blood flow. Despite flunarizine's known selectivity for the cerebral rather than the systemic circulation (2), we found that larger doses were associated with a mild but consistent hypotension. These doses cannot be considered to be excessive a priori, because in view of its very rapid transplacental passage in the rat (2) and the sheep (unpublished data), the dose administered will have rapidly equilibrated with the ewe.
The significant acute mortality seen in three otherwise healthy fetuses found in this study must give rise to caution. We also found that flunarizine was toxic when given to sick fetuses (18); although they would very likely have died anyway, collapse only occurred after infusion was started. Because death in both groups was associated with an abrupt onset of hypotension and bradycardia, this suggests that the toxic effect was primarily cardiac. Inasmuch as many fetuses at risk for asphyxia will have been compromised by acute or chronic placental insufficiency, the very fetuses whom we wish to treat may be least able to tolerate therapy, as shown by the severe hypotension seen after asphyxia with therapy with the water-soluble calcium antagonist nicardipine discussed above (20) .
In summary, this study supports the suggestion that treatment with flunarizine is partially neuroprotective to the fetus when given before a severe hypoxic-ischemic insult. Low-dose therapy was associated with much more rapid recovery after ischemia, suggesting that it reduces the primary injury rather than secondary damage. The propensity to cause hypotension particularly at the higher doses is such that use in high-risk deliveries would be i n a~~r o~r i a t e at Dresent. Additional studies of flunarizine or siiiiar agents, pakicularly using asphyxial insults in utero, are needed to further elucidate the mechanisms of neuronal injury
